With the analysis among 343 patents, we discovered top 32 key players by total patent application. Neurocrine Biosciences, Inc., Astellas Pharma, Inc., AbbVie, Inc. are dominant in this area. They take 61.81% of the total patent filing.
California, United States
Patent: 140
Tokyo-to, Japan
Patent: 45
Illinois, United States
Patent: 27
New Jersey, United States
Patent: 25
Tokyo-to, Japan
Patent: 21
Jiangsu Sheng, China
Patent: 19
Noord-Holland, Netherlands
Patent: 10
Sichuan Sheng, China
Patent: 9
Noord-Holland, Netherlands
Patent: 6
No data, please try another search term
With the analysis among related 49 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing AbbVie, Inc., Vancouver Biotech Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 67.35% of patent filing during this period.
Illinois, United States
Patent: 22
Jiangsu Sheng, China
Patent: 5
Guangdong Sheng, China
Patent: 3
California, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
Genève, Switzerland
Patent: 2
Jiangsu Sheng, China
Patent: 1
Nagano-ken, Japan
Patent: 1
Sichuan Sheng, China
Patent: 1
With the analysis among related 49 patents in last 5 years, we discover 9 new entrants. Vancouver Biotech Ltd., Shenzhen Rentai Pharmaceutical Technology Co., Ltd., ObsEva SA are the most active new entrants in this area.
Guangdong Sheng, China
Patent: 3
Genève, Switzerland
Patent: 2
Guangdong Sheng, China
Patent: 2
Sichuan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Nagano-ken, Japan
Patent: 1
Uttar Pradesh, India
Patent: 1
No data, please try another search term